Suzanne Fuqua on Biopsying Metastatic Tumors

Suzanne A. W. Fuqua, PhD
Published Online: Friday, October 18, 2013
Suzanne A. W. Fuqua, PhD, professor of medicine, Baylor College of Medicine, says that it is an exciting time for the treatment of patients with metastatic breast cancer.

Many women today are consenting to biopsy their metastatic lesions, which is the only way to learn about the mechanisms that evolve during the course of treatment. A metastatic tumor is not the same as a primary tumor, Fuqua says, as it evolves both with and as a function of treatment.

Biopsied lesions allow for the discovery of many new mechanisms of resistance that are targetable. Fuqua says that there are drugs available today that can be combined with hormonal therapies in this space.

Online CME Activities
Free CME from PER
Community Practice Connections™: 16th Annual International Lung Cancer Congress®
Community Practice Connections™: 14th Annual International Congress on the Future of Breast Cancer®
Oncology Consultations®: Integrating Molecular Testing into the Breast Cancer Treatment Paradigm
Role of the Nurse in Facilitating Adherence to Oral Therapies in Oncology Practice
More Reading